search
Back to results

Stimulation to Improve Memory (STIM)

Primary Purpose

Mild Cognitive Impairment, Dementia of Alzheimer Type

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
1 mA HD-tDCS
2 mA HD-tDCS
3 mA HD-tDCS
Sham
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mild Cognitive Impairment focused on measuring Dementia, Memory, Cognitive Rehabilitation, PET scan, fMRI, Brain Stimulation

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Diagnosis of Mild Cognitive Impairment (MCI) or dementia of the Alzheimer's type (DAT)
  2. Must be MRI compatible, criteria that also apply for High Definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head)
  3. Stable on relevant medications for at least 4 weeks prior to study enrollment

Exclusion Criteria:

  1. Certain neurological diseases
  2. Certain psychiatric conditions
  3. Severe sensory impairment

Sites / Locations

  • University of MichiganRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Sham Comparator

Experimental

Experimental

Experimental

Arm Label

Sham Stimulation

1 mA Dosage Stimulation

2 mA Dosage Stimulation

3 mA Dosage Stimulation

Arm Description

Sham (placebo) dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.

1 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.

2 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.

3 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.

Outcomes

Primary Outcome Measures

Change in Lateral Temporal Cortex Connectivity
Graph Theory Analysis via fMRI using arbitrary units of connectivity strength

Secondary Outcome Measures

Self-Report of Contentment with Memory
Multifactorial Memory Questionnaire (MMQ) Contentment Score
Self-Report of Memory Mistakes
Multifactorial Memory Questionnaire (MMQ) Ability Score
Self-Report of Memory Strategies Used
Multifactorial Memory Questionnaire (MMQ) Strategies Score
Change in Memory Functioning
Measured through change in the RBANS Delayed Memory Index
Change in Overall Fluid Cognitive Abilities
Measured through change in the NIH Toolbox Cognition Fluid Composite Score
Cumulative Working Memory Effects of HD-tDCS across daily sessions
Working memory accuracy measured by a discriminability ratio (2-back d' minus 0-back d') on a validated computerized N-Back task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Cumulative Memory Accuracy Effects of HD-tDCS across daily sessions
Verbal memory accuracy measured by an accuracy score (percent correct) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Cumulative Memory Reaction Time Effects of HD-tDCS across daily sessions
Verbal memory reaction time measured by a drift rate score (V; measured by the mean rate at which information is accumulated towards a boundary [correct or error response]) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Tolerability of HD-tDCS
Evaluated using standard questionnaires that arose from comprehensive reviews of the tDCS literature, this questionnaire was recently refined to include pre- and post-HD-tDCS symptom assessment. This will be administered prior to and immediately after every brain stimulation session (including sham).
Effectiveness of Blinding of HD-tDCS
Evaluated using a standard single question administered after every brain stimulation session (including sham).

Full Information

First Posted
March 11, 2019
Last Updated
June 7, 2023
Sponsor
University of Michigan
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT03875326
Brief Title
Stimulation to Improve Memory
Acronym
STIM
Official Title
Testing High Definition Transcranial Direct Current Stimulation (HD-tDCS) as Treatment of Mild Cognitive Impairment
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2019 (Actual)
Primary Completion Date
September 1, 2024 (Anticipated)
Study Completion Date
October 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will test the effects of different doses of a form of non-invasive brain stimulation for the treatment of individuals with mild cognitive impairment (MCI) and dementia of the Alzheimer's Type (DAT).
Detailed Description
This research study is being done to learn important information about the effects of weak electrical stimulation on brain functioning in those with mild cognitive impairment (MCI) and dementia of the Alzheimer's type (DAT). The findings will help determine "how much" stimulation is needed to enhance memory and thinking abilities, how it affects brain functioning, and who is most likely to benefit. Ultimately, this information may guide treatment efforts for those at various stages of Alzheimer's disease. The study will use brain imaging to see whether these treatments change how participants learn and remember information. Functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) scans will be used. The study will also use cognitive tests and questionnaires to examine whether participants' memory (and related abilities) change because of treatment. The study will enroll participants with a diagnosis of MCI or DAT. It is expected but not required that participants will be co-enrolled in the University of Michigan Memory and Aging Project (UM-MAP; HUM00000382).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment, Dementia of Alzheimer Type
Keywords
Dementia, Memory, Cognitive Rehabilitation, PET scan, fMRI, Brain Stimulation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Eligible participants will be randomized 1:1:1:1 to receive either sham, 1mA, 2mA, or 3mA HD-tDCS for at least 5 sessions and up to 30 sessions using a blocked randomization design.
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
240 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sham Stimulation
Arm Type
Sham Comparator
Arm Description
Sham (placebo) dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.
Arm Title
1 mA Dosage Stimulation
Arm Type
Experimental
Arm Description
1 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.
Arm Title
2 mA Dosage Stimulation
Arm Type
Experimental
Arm Description
2 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.
Arm Title
3 mA Dosage Stimulation
Arm Type
Experimental
Arm Description
3 milliAmp dose of HD-tDCS treatment for 30 minutes, for between 5-30 sessions.
Intervention Type
Device
Intervention Name(s)
1 mA HD-tDCS
Intervention Description
Participants will receive HD-tDCS at 1 mA for 30 minutes, for between 5-30 sessions.
Intervention Type
Device
Intervention Name(s)
2 mA HD-tDCS
Intervention Description
Participants will receive HD-tDCS at 2 mA for 30 minutes, for between 5-30 sessions.
Intervention Type
Device
Intervention Name(s)
3 mA HD-tDCS
Intervention Description
Participants will receive HD-tDCS at 3 mA for 30 minutes, for between 5-30 sessions.
Intervention Type
Device
Intervention Name(s)
Sham
Intervention Description
Participants will receive sham (placebo) HD-tDCS for 30 minutes, for between 5-30 sessions.
Primary Outcome Measure Information:
Title
Change in Lateral Temporal Cortex Connectivity
Description
Graph Theory Analysis via fMRI using arbitrary units of connectivity strength
Time Frame
Baseline fMRI and post-intervention (after tDCS sessions 5 & 30)
Secondary Outcome Measure Information:
Title
Self-Report of Contentment with Memory
Description
Multifactorial Memory Questionnaire (MMQ) Contentment Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Self-Report of Memory Mistakes
Description
Multifactorial Memory Questionnaire (MMQ) Ability Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Self-Report of Memory Strategies Used
Description
Multifactorial Memory Questionnaire (MMQ) Strategies Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Memory Functioning
Description
Measured through change in the RBANS Delayed Memory Index
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Overall Fluid Cognitive Abilities
Description
Measured through change in the NIH Toolbox Cognition Fluid Composite Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Cumulative Working Memory Effects of HD-tDCS across daily sessions
Description
Working memory accuracy measured by a discriminability ratio (2-back d' minus 0-back d') on a validated computerized N-Back task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Time Frame
Baseline Session through Session 6 then weekly up to final session
Title
Cumulative Memory Accuracy Effects of HD-tDCS across daily sessions
Description
Verbal memory accuracy measured by an accuracy score (percent correct) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Time Frame
Baseline Session through Session 6 then weekly up to final session
Title
Cumulative Memory Reaction Time Effects of HD-tDCS across daily sessions
Description
Verbal memory reaction time measured by a drift rate score (V; measured by the mean rate at which information is accumulated towards a boundary [correct or error response]) on a computerized Paired Associates task, measured after baseline (Session 1) and every intervention session (Sessions 2-6)
Time Frame
Baseline Session through Session 6 then weekly up to final session
Title
Tolerability of HD-tDCS
Description
Evaluated using standard questionnaires that arose from comprehensive reviews of the tDCS literature, this questionnaire was recently refined to include pre- and post-HD-tDCS symptom assessment. This will be administered prior to and immediately after every brain stimulation session (including sham).
Time Frame
Prior to and immediately following each HD-tDCS session (<60 Minutes)
Title
Effectiveness of Blinding of HD-tDCS
Description
Evaluated using a standard single question administered after every brain stimulation session (including sham).
Time Frame
Immediately following HD-tDCS sessions 5 and final session (<60 Minutes)
Other Pre-specified Outcome Measures:
Title
Change in Default Mode Network Connectivity
Description
Graph Theory Analysis via fMRI using arbitrary units of connectivity strength to measure changes in the Default Mode Network, along with strength in and between other networks
Time Frame
Baseline fMRI and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Inhibition Ability
Description
A priori intent to measure through change in the NIH Toolbox Flanker Inhibitory Control and Attention Test Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Conceptualization Ability
Description
A priori intent to measure through change in the NIH Toolbox Dimensional Change Card Sort Test Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Picture Sequence Memory
Description
A priori intent to measure through change in the NIH Toolbox Picture Sequence Memory Test Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Working Memory Ability
Description
A priori intent to measure through change in the NIH Toolbox List Sorting Working Memory Test Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Processing Speed
Description
A priori intent to measure through change in the NIH Toolbox Pattern Comparison Processing Speed Test Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Cumulative Working Memory Performance Effects of HD-tDCS across daily sessions
Description
A priori intent to explore d' change for each N-Back task condition (2-back, 0-back) in order to understand the overall effect of the HD-tDCS on task performance.
Time Frame
Baseline Session through Session 6 then weekly up to final session
Title
Change in Global Cognition
Description
Measured through change in the Total RBANS Score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Visuospatial Functioning
Description
Measured through change in the RBANS Visuospatial Index score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Language Functioning
Description
Measured through change in the RBANS Language Index score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Attention
Description
Measured through change in the RBANS Attention Index score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Memory Functioning
Description
Measured through change in the RBANS Immediate Memory Index score
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Change in Cognitive Functioning
Description
A priori intent to measure through changes in RBANS subtest scores
Time Frame
Baseline and post-intervention (after tDCS sessions 5 & 30)
Title
Cumulative Cognitive Change across Daily Consecutive Sessions
Description
Measured through change in Cogstate or other comparable computerized cognitive testing scores across consecutive daily sessions
Time Frame
After each HD-tDCS Session, daily

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Mild Cognitive Impairment (MCI) or dementia of the Alzheimer's type (DAT) Must be MRI compatible, criteria that also apply for High Definition transcranial direct current stimulation (HD-tDCS; e.g., absence of metallic or electronic implants in the upper body or head) Stable on relevant medications for at least 4 weeks prior to study enrollment Exclusion Criteria: Certain neurological diseases Certain psychiatric conditions Severe sensory impairment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stephen M Schlaefflin, BS
Phone
734-936-7360
Email
schlst@med.umich.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Eileen A Robinson, RN-BC
Phone
734-763-1356
Email
robinsoe@med.umich.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin Hampstead, PhD
Organizational Affiliation
Associate Professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48105
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stephen M Schlaefflin, BS
Phone
734-936-7360
Email
schlst@med.umich.edu
First Name & Middle Initial & Last Name & Degree
Eileen Robinson, RN-BC, MPH, CCRC
Phone
734-763-1356
Email
robinsoe@med.umich.edu
First Name & Middle Initial & Last Name & Degree
Benjamin Hampstead, PhD
First Name & Middle Initial & Last Name & Degree
Annalise Rahman-Filipiak, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Stimulation to Improve Memory

We'll reach out to this number within 24 hrs